StockData
Amgen Inc logo

Amgen Inc (AMGN) operating KPIs

AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)

Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%

Amgen weighted-average diluted shares (M) (M)

Form 10-Q / 10-K (DB)

QuarterlyAnnual
Latest, Q2 2026
544
Period ended Jun 30, 2026
Change on a year earlier
+0.6%
541 in Q2 2025
History
45 quarters
Since Q2 2008
Sources
42
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedWeighted-average diluted shares (M) (M)Year on yearSource
Q2 2026Jun 30, 2026544+0.6%Form 10-Q (filed 2026-08-05) ↗
Q1 2026Mar 31, 2026544+0.6%Form 10-Q (filed 2026-05-01) ↗
Q3 2025Sep 30, 20255420.0%Form 10-Q (filed 2025-11-05) ↗
Q2 2025Jun 30, 20255410.0%Form 10-Q (filed 2025-08-06) ↗
Q1 2025Mar 31, 2025541+0.9%Form 10-Q (filed 2025-05-02) ↗
Q3 2024Sep 30, 2024542+0.7%Form 10-Q (filed 2024-10-31) ↗
Q2 2024Jun 30, 2024541+0.7%Form 10-Q (filed 2024-08-07) ↗
Q1 2024Mar 31, 2024536-0.4%Form 10-Q (filed 2024-05-03) ↗
Q3 2023Sep 30, 20235380.0%Form 10-Q (filed 2023-10-31) ↗
Q2 2023Jun 30, 20235370.0%Form 10-Q (filed 2023-08-04) ↗
Q1 2023Mar 31, 2023538-2.4%Form 10-Q (filed 2023-04-28) ↗
Q3 2022Sep 30, 2022538–Form 10-Q (filed 2022-11-04) ↗
Q2 2022Jun 30, 2022537–Form 10-Q (filed 2022-08-05) ↗
Q1 2022Mar 31, 2022551-5.2%Form 10-Q (filed 2022-04-28) ↗
Q1 2021Mar 31, 2021581-2.2%Form 10-Q (filed 2021-04-28) ↗
Q3 2020Sep 30, 2020589–Form 10-Q (filed 2020-10-29) ↗

Cite this data

StockData. (2026). Amgen Weighted-average diluted shares (M) (M), quarterly Q2 2008–Q2 2026 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/fs_sh_diluted

See every metric in the Amgen KPI table. Data updated Oct 28, 2026.